Provepharm Inc. is recalling 10,800 ampules (2,160 packs) of Dihydroergotamine Mesylate Injection (1 mg/mL), a prescription medication used to treat migraine headaches. The recall was initiated because the solution in the ampules may show discoloration. Consumers should check their supply for lot numbers F9026F01 and F9026F02 with an expiration date of December 2025. Provepharm Inc. notified customers of this voluntary recall via letter.
Discoloration in an injectable medication indicates a potential change in the drug's chemical stability or composition. Using discolored medication may result in reduced effectiveness of the treatment or could potentially cause an adverse reaction when administered.
You have 2 options:
Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426. Quantity: 2160 packs/5 ampules per pack = 10,800 ampules.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.